Zosano Pharma set to add to rally, up 20% premarket

|About: Zosano Pharma (ZSAN)|By:, SA News Editor

Zosano Pharma (NASDAQ:ZSAN) is up 20% premarket on increased volume. Shares have rallied over four-fold since February 23.

A week ago, the company was awarded a new U.S. patent protecting lead candidate M207.

Previously: Zosano Pharma issues new U.S. patent covering M207 as an acute treatment for migraine (March 2)

Subscribe for full text news in your inbox